Oncology

The Roche Group is the world’s leading provider of cancer care products. Our anti-cancer medicines are saving lives and significantly advancing the way some cancers are treated. The Roche portfolio currently includes five innovative cancer products proven to provide survival benefit in a number of different tumor types: Avastin® (bevacizumab), Herceptin® (trastuzumab), Xeloda® (capecitabine), MabThera® (rituximab) and Tarceva® (erlotinib).

In addition, Roche is developing new diagnostic tests that will have a significant impact on disease management for cancer patients in the future. With a broad portfolio of tumour markers as well as a range of molecular oncology tests, Roche will continue to be one of the leaders in providing cancer-focused treatments and diagnostics.

	Title	Type
Documents
	About Roche in oncology	PDF
	Breast cancer backgrounder	PDF
	Cancer - a major global health challenge	PDF
	Cancer facts backgrounder	PDF
	Chronic Lymphocytic Leukemia backgrounder	PDF
	Colorectal cancer backgrounder	PDF
	Non-Hodgkin's Lymphoma backgrounder	PDF
	Non Small Cell Lung Cancer backgrounder	PDF
	Roche in Oncology backgrounder	PDF
	Roche Oncology R&D	PDF (2.7 MB)
	Skin Cancer (Melanoma) backgrounder	PDF
Video
	Avastin Production	ZIP
Illustrations
	Stomach cancer	JPG
	Staging of stomach cancer	JPG
	Testing visuals - IHC Testing	JPG
Images
	Xeloda pack shot	JPG (3.7 MB)
	Oral chemotherapy Xeloda pill	JPG
	Oral chemotherapy Xeloda in hand	JPG (4.1 MB)
	Tarceva pill	JPG